HCT

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid LeukemiaNCT02665065Actinium PharmaceuticalsPhase 3Active not recruiting2022-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.